JP2007509900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509900A5 JP2007509900A5 JP2006537238A JP2006537238A JP2007509900A5 JP 2007509900 A5 JP2007509900 A5 JP 2007509900A5 JP 2006537238 A JP2006537238 A JP 2006537238A JP 2006537238 A JP2006537238 A JP 2006537238A JP 2007509900 A5 JP2007509900 A5 JP 2007509900A5
- Authority
- JP
- Japan
- Prior art keywords
- hypertension
- pharmaceutically acceptable
- acceptable salt
- combination
- restenosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0325605.4A GB0325605D0 (en) | 2003-11-03 | 2003-11-03 | Combination of organic compounds |
| PCT/EP2004/012386 WO2005049013A1 (en) | 2003-11-03 | 2004-11-02 | Combinations of at1-antagonists, amiloride or triamterine, and a diuretic. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509900A JP2007509900A (ja) | 2007-04-19 |
| JP2007509900A5 true JP2007509900A5 (https=) | 2007-12-13 |
Family
ID=29725841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006537238A Pending JP2007509900A (ja) | 2003-11-03 | 2004-11-02 | Ａｔ１−アンタゴニスト、アミロライドまたはトリアメテリンおよび利尿剤の組み合わせ |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20070072848A1 (https=) |
| EP (1) | EP1682122B9 (https=) |
| JP (1) | JP2007509900A (https=) |
| KR (1) | KR20060097025A (https=) |
| CN (1) | CN1878548A (https=) |
| AT (1) | ATE389399T1 (https=) |
| AU (1) | AU2004290505B2 (https=) |
| BR (1) | BRPI0416154A (https=) |
| CA (1) | CA2544230A1 (https=) |
| DE (1) | DE602004012593T2 (https=) |
| ES (1) | ES2303958T3 (https=) |
| GB (1) | GB0325605D0 (https=) |
| PL (1) | PL1682122T3 (https=) |
| PT (1) | PT1682122E (https=) |
| RU (1) | RU2006119329A (https=) |
| WO (1) | WO2005049013A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090062309A1 (en) * | 2007-08-28 | 2009-03-05 | Antonio Delgado-Almeida | Therapeutic compositions for the treatment of cardiovascular diseases and methods for use therefor |
| WO2012152718A1 (en) | 2011-05-06 | 2012-11-15 | Farmicom Pharmaceutical Company D.O.O. | Composition comprising angiotensin ii receptor antagonist and antioxidant for maintaining and/or improving skin properties |
| CN102793703A (zh) * | 2011-05-25 | 2012-11-28 | 苏州洪瑞医药科技有限公司 | 一种盐酸阿米洛利和环戊噻嗪的药物组合物及其制备方法 |
| WO2018027550A1 (en) * | 2016-08-09 | 2018-02-15 | Shanghai Yao Yuan Biotechnology Co., Ltd. | Methods and compositions for appetite control and weight management |
| CN109364248B (zh) * | 2018-10-16 | 2021-05-18 | 哈尔滨医科大学 | ENaC及其抑制剂在预防、缓解和/或治疗动脉粥样硬化中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| US6323226B1 (en) * | 1999-10-19 | 2001-11-27 | Texas Heart Institute | Treatment of heart disease with cox-2 inhibitors |
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| US20040087484A1 (en) * | 2000-12-01 | 2004-05-06 | Sahota Pritam Singh | Combination of organic compounds |
| EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
-
2003
- 2003-11-03 GB GBGB0325605.4A patent/GB0325605D0/en not_active Ceased
-
2004
- 2004-02-11 US US10/577,370 patent/US20070072848A1/en not_active Abandoned
- 2004-11-02 DE DE602004012593T patent/DE602004012593T2/de not_active Revoked
- 2004-11-02 CA CA002544230A patent/CA2544230A1/en not_active Abandoned
- 2004-11-02 BR BRPI0416154-8A patent/BRPI0416154A/pt not_active IP Right Cessation
- 2004-11-02 WO PCT/EP2004/012386 patent/WO2005049013A1/en not_active Ceased
- 2004-11-02 KR KR1020067008517A patent/KR20060097025A/ko not_active Withdrawn
- 2004-11-02 JP JP2006537238A patent/JP2007509900A/ja active Pending
- 2004-11-02 EP EP04797529A patent/EP1682122B9/en not_active Revoked
- 2004-11-02 CN CNA2004800329189A patent/CN1878548A/zh active Pending
- 2004-11-02 PL PL04797529T patent/PL1682122T3/pl unknown
- 2004-11-02 PT PT04797529T patent/PT1682122E/pt unknown
- 2004-11-02 ES ES04797529T patent/ES2303958T3/es not_active Expired - Lifetime
- 2004-11-02 RU RU2006119329/15A patent/RU2006119329A/ru not_active Application Discontinuation
- 2004-11-02 AT AT04797529T patent/ATE389399T1/de not_active IP Right Cessation
- 2004-11-02 AU AU2004290505A patent/AU2004290505B2/en not_active Ceased
-
2008
- 2008-09-26 US US12/286,039 patent/US20090036432A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2322174B1 (en) | Combined use of valsartan and calcium channel blockers for therapeutic purposes | |
| DE60117295T2 (de) | Synergistische kombinationen mit einem renin-inhibitor für kardiovaskuläre erkrankungen | |
| JP4938905B2 (ja) | 選択的ｓ１ｐ１レセプターアゴニストの投与法 | |
| Cherney et al. | The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes | |
| JP2020529996A5 (https=) | ||
| US20080027032A1 (en) | Combinations comprising cox-2 inhibitors and aspirin | |
| JP2018532720A (ja) | 線維症の治療のためのセニクリビロック併用療法 | |
| JP2015205909A (ja) | 組合せ | |
| JP2010514696A (ja) | 心血管症状の低減 | |
| EA015382B1 (ru) | Применение рофлумиласта для лечения сахарного диабета типа 2 | |
| US20260102472A1 (en) | Semaglutide in medical therapy | |
| DE602004012763T2 (de) | Pharmazeutische zusammensetzung mit einem selektiven i1 imidazolin-rezeptor-agonisten und einem angiotensin-ii-rezeptorblocker | |
| JP2007509900A5 (https=) | ||
| US20090036432A1 (en) | Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic | |
| JP2021075470A (ja) | 肺線維症の予防または治療のための医薬 | |
| US20160199354A1 (en) | Methods for olmesartan dosing by auc | |
| TW200538154A (en) | Combination of organic compounds | |
| CN120093759B (zh) | 一种预防或治疗动脉硬化的药物组合物及其应用 | |
| US20060122217A1 (en) | Combination of organic compounds | |
| RU2778313C2 (ru) | Лекарственная композиция, включающая ингибитор sglt-2 и блокатор рецептора ангиотензина | |
| Brunner et al. | Treatment of hypertension with ACE inhibitors as first step: pharmacologic and clinical considerations | |
| WO2017149105A1 (en) | Liraglutide in renal conditions | |
| MXPA06004933A (en) | Combinations of at1-antagonists, amiloride or triamterine, and a diuretic | |
| HK1152897B (en) | Combined use of valsartan and calcium channel blockers for therapeutic purposes | |
| CN101119727A (zh) | 利莫那班在制备用于预防和治疗2型糖尿病的药物中的用途 |